Show simple item record

dc.contributor.authorChioncel, Ovidiu
dc.contributor.authorMebazaa, Alexandre
dc.contributor.authorHarjola, Veli-Pekka
dc.contributor.authorCoats, Andrew J.
dc.contributor.authorPiepoli, Massimo Francesco
dc.contributor.authorCrespo-Leiro, María Generosa
dc.contributor.authorLaroche, Cecile
dc.contributor.authorSeferovic, Petar M.
dc.contributor.authorAnker, Stefan
dc.contributor.authorFerrari, Roberto
dc.contributor.authorRuschitzka, Frank
dc.contributor.authorLópez-Fernández, Silvia
dc.contributor.authorMiani, Daniela
dc.contributor.authorFilippatos, Gerasimos
dc.contributor.authorMaggioni, Aldo P.
dc.date.accessioned2019-01-14T11:09:34Z
dc.date.available2019-01-14T11:09:34Z
dc.date.issued2017-04-30
dc.identifier.citationChioncel O, Mebazza A, Harjola VP, et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long‐Term Registry. Eur J Heart Fail. 2017; 19(10): 1242-1254es_ES
dc.identifier.issn1388-9842
dc.identifier.urihttp://hdl.handle.net/2183/21579
dc.description.abstract[Abstract] Aims. To identify differences in clinical epidemiology, in‐hospital management and 1‐year outcomes among patients hospitalized for acute heart failure (AHF) and enrolled in the European Society of Cardiology Heart Failure Long‐Term (ESC‐HF‐LT) Registry, stratified by clinical profile at admission. Methods and results. The ESC‐HF‐LT Registry is a prospective, observational study collecting hospitalization and 1‐year follow‐up data from 6629 AHF patients. Among AHF patients enrolled in the registry, 13.2% presented with pulmonary oedema (PO), 2.9% with cardiogenic shock (CS), 61.1% with decompensated heart failure (DHF), 4.8% with hypertensive heart failure (HT‐HF), 3.5% with right heart failure (RHF) and 14.4% with AHF and associated acute coronary syndromes (ACS‐HF). The 1‐year mortality rate was 28.1% in PO, 54.0% in CS, 27.2% in DHF, 12.8% in HT‐HF, 34.0% in RHF and 20.6% in ACS‐HF patients. When patients were classified by systolic blood pressure (SBP) at initial presentation, 1‐year mortality was 34.8% in patients with SBP <85 mmHg, 29.0% in those with SBP 85–110 mmHg, 21.2% in patients with SBP 110–140 mmHg and 17.4% in those with SBP >140 mmHg. These differences tended to diminish in the months post‐discharge, and 1‐year mortality for the patients who survived at least 6 months post‐discharge did not vary significantly by either clinical profile or SBP classification. Conclusion. Rates of adverse outcomes in AHF remain high, and substantial differences have been found when patients were stratified by clinical profile or SBP. However, patients who survived at least 6 months post‐discharge represent a more homogeneous group and their 1‐year outcome is less influenced by clinical profile or SBP at admission.es_ES
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.relation.urihttps://doi.org/10.1002/ejhf.890es_ES
dc.subjectAcute heart failurees_ES
dc.subjectClinical profilees_ES
dc.subjectOutcomeses_ES
dc.titleClinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long‐Term Registryes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessinfo:eu-repo/semantics/openAccesses_ES
UDC.journalTitleEuropean Journal of Heart Failurees_ES
UDC.volume19es_ES
UDC.issue10es_ES
UDC.startPage1242es_ES
UDC.endPage1254es_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record